Skip to main content
. 2013 Jan 15;15(1):R4. doi: 10.1186/bcr3375

Figure 2.

Figure 2

The biomarker panel including ITIH5, DKK3, and RASSF1A enables significant discrimination of breast cancer sera from various control conditions. Scatterplot illustrating the mean PMR values of the three-gene panel in the independent validation set. Combination of DKK3 and ITIH5 with RASSF1A increased the sensitivity to 67% (92 of 138) with a specificity of 69% (93 of 135) and 82% (32 of 39) in healthy and benign disease controls, respectively. ***P < 0.0001.